Nov 1, 20162 minAcesion Pharma raises 9.1 million EUR in first closing of new funding from Novo Seeds and Wellcome TAcesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), today announced that it has raised 9.1...
Sep 30, 20161 minAcesion Pharma appoints experienced CMC executive Breian Knudsen as VP CMCAcesion Pharma, a pharmaceutical company developing novel first-in-class drugs to treat atrial fibrillation (AF), announced today that it...
Jul 31, 20161 minAcesion Pharma appoints experienced clinical leader Christina Sylvest as SVP acute cardioversionAcesion Pharma, a pharmaceutical company developing novel first-in-class drugs to treat atrial fibrillation (AF), announced today that it...